Trial intelligence / Profile preview

Raloxifene for negative symptoms of schizophrenia in post-menopausal women

NCT01573637Phase 3Completed

Sponsor
Fundació Sant Joan de Déu
Start
Jul 2011
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of raloxifene in schizophrenia, sponsored by Fundació Sant Joan de Déu. Started Jul 2011; status: completed.

02

Drugs

raloxifene
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT01573637.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01573637.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call